| A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF (NCT01566578) | Ennar Pharmaceuticals AF | 2012-04-01 |
| Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173 (NCT02217839) | Aspireo Pharmaceuticals Limited | 2012-04-01 |
| A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen (NCT01497470) | Achieve Life Sciences | 2012-04-01 |
| Improving Symptom Management for Cancer Patients and Their Caregivers Through Internet (NCT01867723) | Oslo University Hospital | 2012-04-01 |
| Testosterone Replacement for Male Opioid Agonist Maintained Patients (NCT01873989) | Yale University | 2012-04-01 |
| Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease (NCT01331122) | Chelsea Therapeutics | 2012-04-01 |
| Sanaria™ PfSPZ Challenge Vaccine (NCT01546389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly (NCT01661894) | Duke-NUS Graduate Medical School | 2012-04-01 |
| Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia (NCT01491594) | Duke University | 2012-04-01 |
| A Study of LY2140023 in Healthy Males and Females (NCT01591330) | Denovo Biopharma LLC | 2012-04-01 |
| A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis (NCT01484561) | Pfizer | 2012-04-01 |
| Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects (NCT01568281) | AstraZeneca | 2012-04-01 |
| Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients (NCT01525628) | Boehringer Ingelheim | 2012-04-01 |
| Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo (NCT02682121) | University of Utah | 2012-04-01 |
| Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency (NCT03315078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer (NCT01484041) | Georgetown University | 2012-04-01 |
| Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea (NCT01579084) | Allergan | 2012-04-01 |
| Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection (NCT01767415) | Weill Medical College of Cornell University | 2012-04-01 |
| Phase I Pharmacokinetic Study (SALBLOCK) (NCT01564199) | Orion Corporation, Orion Pharma | 2012-04-01 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors (NCT01577745) | MedImmune LLC | 2012-04-01 |
| Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib (NCT01544140) | Sanofi | 2012-04-01 |
| Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol (NCT01578057) | Vanda Pharmaceuticals | 2012-04-01 |
| Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis (NCT01577550) | AbbVie | 2012-04-01 |
| Daptomycin in Pediatric Patients With Bacterial Meningitis (NCT01522105) | Insel Gruppe AG, University Hospital Bern | 2012-04-01 |
| Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) (NCT01521780) | Merck Sharp & Dohme LLC | 2012-04-01 |
| Dose-Escalation and Safety Trial of YN968D1 (NCT01497704) | Elevar Therapeutics | 2012-04-01 |
| Assessment of a New Surgical Smoke Clearing Technology in Laparoscopic Cholecystectomy (NCT01534832) | Asalus Medical Instruments Limited | 2012-04-01 |
| Clinical Efficacy of Atomoxetine for Methamphetamine Dependence (NCT01557569) | University of Arkansas | 2012-04-01 |
| A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy Volunteers (NCT01558362) | Ottawa Heart Institute Research Corporation | 2012-04-01 |
| Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients (NCT01493154) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-04-01 |
| Safety and Pharmacokinetic Study of Y242 in Adult Subjects (NCT01515319) | Imperial College London | 2012-04-01 |
| Safety Tolerability and Pharmacokinetic of BI 411034 (NCT01581684) | Boehringer Ingelheim | 2012-04-01 |
| Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population (NCT01755637) | GlaxoSmithKline | 2012-04-01 |
| Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa (NCT01604356) | Johns Hopkins University | 2012-04-01 |
| Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) (NCT01778920) | University of Pennsylvania | 2012-04-01 |
| Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury (NCT01624779) | Bukwang Pharmaceutical | 2012-04-01 |
| A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer (NCT01615406) | Molecular Insight Pharmaceuticals, Inc. | 2012-04-01 |
| Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01533194) | National Cancer Institute (NCI) | 2012-04-01 |
| Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment (NCT01580306) | Boehringer Ingelheim | 2012-04-01 |
| rTMS for Adults With Autistic Spectrum Disorder (NCT01918787) | Chang Gung Memorial Hospital | 2012-04-01 |
| Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir (NCT01582035) | Janssen R&D Ireland | 2012-04-01 |
| Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction (NCT01595360) | Thrombotargets Europe S.L | 2012-04-01 |
| Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis (NCT01860170) | Corewell Health West | 2012-04-01 |
| A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas (NCT01588678) | Daiichi Sankyo | 2012-04-01 |
| Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium (NCT01623050) | SinuSys Corporation | 2012-04-01 |
| Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition (NCT01722110) | IPCA Laboratories Ltd. | 2012-04-01 |
| Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors (NCT01479023) | Washington University School of Medicine | 2012-04-01 |
| Effects of Purple Vegetables on Cardiovascular Disease (CVD) Risk Factors (NCT01564498) | University of Guelph | 2012-04-01 |
| A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma (NCT01547546) | Genentech, Inc. | 2012-04-01 |
| A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML) (NCT01468467) | Daiichi Sankyo | 2012-04-01 |
| A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers (NCT01587313) | Arbor Pharmaceuticals, Inc. | 2012-04-01 |
| Impact of Grape Consumption on Brain Metabolism and Cognitive Function (NCT01573611) | University of California, Los Angeles | 2012-04-01 |
| Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects (NCT01554319) | Sterna Biologicals GmbH & Co. KG | 2012-04-01 |
| Safety Trial of Live Attenuated Influenza (H7N3) Vaccine (NCT01511419) | PATH | 2012-04-01 |
| Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies (NCT01413568) | Polyphor Ltd. | 2012-04-01 |
| Nesiritide in Resistant Hypertension (NCT01514357) | John C Burnett | 2012-04-01 |
| A Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Facial Wrinkles(Nasolabial Folds) (NCT01644461) | Kasiak Research Pvt. Ltd. | 2012-04-01 |
| Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma (NCT01576692) | St. Jude Children's Research Hospital | 2012-04-01 |
| A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1 (NCT01594320) | Novavax | 2012-04-01 |
| A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects (NCT01797198) | Astellas Pharma Europe B.V. | 2012-04-01 |
| Transition From Alendronate to Romosozumab (AMG 785) (NCT01588509) | Amgen | 2012-03-30 |
| A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer (NCT01625260) | Altor BioScience | 2012-03-30 |
| Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment (NCT01571999) | GlaxoSmithKline | 2012-03-29 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers (NCT01497392) | Roswell Park Cancer Institute | 2012-03-29 |
| Mechanisms Accounting for Unexplained Anemia in the Elderly (NCT01572506) | National Institute on Aging (NIA) | 2012-03-29 |
| A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (NCT01604889) | Incyte Corporation | 2012-03-29 |
| Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy Volunteers (NCT01552928) | Shire | 2012-03-29 |
| A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers (NCT01587703) | GlaxoSmithKline | 2012-03-28 |
| Minocycline to Treat Branch Retinal Vein Occlusion (NCT01468831) | National Eye Institute (NEI) | 2012-03-28 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057 (NCT01587807) | GlaxoSmithKline | 2012-03-28 |
| Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies (NCT01554371) | University of California, San Francisco | 2012-03-27 |
| Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT01526928) | Clovis Oncology, Inc. | 2012-03-27 |
| Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies (NCT01643499) | University of Chicago | 2012-03-26 |
| Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B (NCT01505062) | Sanofi | 2012-03-26 |
| Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder (NCT01919008) | Astellas Pharma Inc | 2012-03-26 |
| Temsirolimus in Combination With Metformin in Patients With Advanced Cancers (NCT01529593) | M.D. Anderson Cancer Center | 2012-03-26 |
| Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer (NCT01433172) | H. Lee Moffitt Cancer Center and Research Institute | 2012-03-26 |
| A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia (NCT01683279) | Seattle Children's Hospital | 2012-03-25 |
| A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma (NCT01564251) | Genentech, Inc. | 2012-03-23 |
| Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL (NCT03016377) | UNC Lineberger Comprehensive Cancer Center | 2012-03-22 |
| A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy (NCT01218854) | National Institutes of Health Clinical Center (CC) | 2012-03-20 |
| Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant (NCT01578317) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-20 |
| A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body (NCT01529684) | Astellas Pharma Global Development, Inc. | 2012-03-19 |
| Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors (NCT01552356) | National Cancer Institute (NCI) | 2012-03-19 |
| Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (NCT02018250) | U.S. Army Medical Research and Development Command | 2012-03-17 |
| Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder (NCT01539707) | Astellas Pharma Inc | 2012-03-13 |
| Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients (NCT01688739) | Amgen | 2012-03-13 |
| Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects (NCT01555749) | Novo Nordisk A/S | 2012-03-12 |
| Brain Imaging, Genetics and Treatment for Major Depression (NCT01568684) | National Institute of Mental Health (NIMH) | 2012-03-12 |
| Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1) (NCT01682811) | Harry T Whelan, MD | 2012-03-12 |
| Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer (NCT01322802) | University of Washington | 2012-03-06 |
| Staged Phase I/II Hepatitis C Prophylactic Vaccine (NCT01436357) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-06 |
| FdCyd and THU for Advanced Solid Tumors (NCT01534598) | National Cancer Institute (NCI) | 2012-03-05 |
| A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers (NCT01577680) | GlaxoSmithKline | 2012-03-05 |
| Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery (NCT01537107) | Mayo Clinic | 2012-03-05 |
| Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease (NCT01568645) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-03-02 |
| Pharmacokinetics Study of ALO-02 and OxyContin (NCT01557257) | Pfizer | 2012-03-01 |
| Sildenafil and Stroke Recovery (NCT02628847) | University of Utah | 2012-03-01 |
| Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118 (NCT01533155) | AstraZeneca | 2012-03-01 |
| Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (NCT01280240) | Pharmacosmos A/S | 2012-03-01 |